USA TODAY International Edition

Experts condemn messy rollout

- Karen Weintraub and Elizabeth Weise

The government needs to learn from Disneyland, bank teller lines and airline reservatio­n systems, USA TODAY’s panel of vaccine experts said.

Nearly unanimous in condemning the messy COVID- 19 vaccine distributi­on rollout so far, the group also expects the operation will improve under the Biden administra­tion.

What has been lacking, nearly all said, is strong leadership at the national level.

“Federal leadership failed to prepare fully to neutralize this pandemic. They concentrat­ed on the vaccine with much less regard to vaccinatio­n,” said Dr. Kelly Moore, Dr. Kelly Moore, deputy director of the nonprofit Immunizati­on Action Coalition. “There’s a need for stability, reliabilit­y, and a process people can trust.”

Improved direction, funding, coordinati­on and communicat­ion – which Biden has promised to provide – should solve the problem of getting vaccine from pharmacy freezers and shelves into people’s arms, panelists said.

“Those factors, along with consistent, fact- based communicat­ions, will help us begin to build up the public’s confidence in these vaccines and in vaccinatio­n,” Moore said.

So far, the government under President Donald Trump has delivered more than 31 million doses of the two vaccines across America. But only 12 million – or about 39% – have been used.

What’s needed, the panelists said, are mass vaccinatio­n clinics that together with other distributi­on methods can deliver more than 1 million

shots a day. Biden has promised 100 million shots will be given during his first 100 days in office, which starts Wednesday.

A national scheduling tool would be a first step, according to several panel members, including Prashant Yadav, a medical supply chain expert and senior fellow with the Center for Global Developmen­t, an internatio­nal developmen­t think tank based in Washington, D. C., and London.

Disneyland knows how to schedule to maximize riders and minimize lines by giving people hourly arrival windows instead of precise times, he said. Customers waiting for bank tellers join a common line, which moves faster than five separate ones.

And airlines prioritize seating to keep first- class passengers happy, he noted. Why can’t the same be done for people who should be prioritize­d to receive vaccinatio­ns?

Right now, every state is on its own to figure out how to schedule. But, Yadav said, “providing a scheduling software is a thing we should do federally, so we have economies of scale and scope – in communicat­ing about it, in training people to use it and in getting the data back.”

More funding for pandemic- weary state and local health department­s also is essential, according to the panel. Although Congress allocated $ 3 billion in December for vaccine distributi­on, that money has yet to arrive in states, and when it does, it will take time to make a difference.

The 15 USA TODAY panelists, who have expertise in everything from virology to logistics, remain optimistic that the vast majority of Americans who want a vaccine will be able to get one by summer.

Every month since June, we have asked panelists what time it is on an imaginary clock that started ticking at midnight a year ago, when people were first infected with the new coronaviru­s. It will reach high noon when vaccine is widely available to all Americans. Each month, we calculate the median time – the midpoint of their estimates.

Starting at 4 a. m., the clock moved forward an hour every month, except November, when it jumped ahead 90 minutes, buoyed by the results of the first two vaccine trials. This month, the clock barely budged, advancing only 6 minutes, from 10: 30 a. m. to 10: 36 a. m.

Speeding up distributi­on

Some of the panelists envision mass vaccinatio­n campaigns with most people scheduled to keep lines moving and vaccinator­s busy.

“We need high throughput,” said Dr. Monica Gandhi, a professor of medicine and infectious disease expert at the University of California- San Francisco.

Volunteers without medical training can log people in before passing them to others who can administer consent forms. Then, trained medical personnel can deliver the shots, while a final medical group watches people for 15 minutes after vaccinatio­n to make sure they don’t have adverse reactions.

To get as many people vaccinated as possible, the vaccinator­s should never be waiting, Yadav said.

“The scarcest resource in the system is the vaccinator. This system doesn’t let the vaccinator­s’ time go idle,” he said.

Gandhi said there should be online reservatio­ns, but also drop- in slots. “Because of the digital divide and language barriers, you need both,” she said.

Such sites should be in addition to shots given at doctors’ offices, clinics, pharmacies and local health centers. But the mass vaccinatio­n centers would allow large numbers of people to get immunized even while smaller settings reach those more reticent about the vaccine or live outside population centers, said Gandhi.

Nursing and medical students can be conscripte­d into the effort, along with other nontraditi­onal health care workers, said Prakash Nagarkatti, vice president for research at the University of South Carolina.

“All states should have engaged such volunteers several months before the vaccine rollout,” he said.

While several panelists praised the Trump administra­tion for getting two vaccines to the finish line, with three more closing in, they criticized the lack of foresight to get vaccine from loading docks into arms.

“There was total lack of planning at the state level for mass vaccinatio­n, and the federal government did not help the states overcome the hurdles,” Nagarkatti said.

“We spent so much time on science and manufactur­ing and politics and we completely dropped the ball on logistics,” said Peter Pitts, president and co- founder of the Center for Medicine in the Public Interest, a nonprofit research group.

It’s something the United States has never been good at, said Arti Rai, a law professor and health law expert at Duke University Law School.

“Since the days of Vannevar Bush in World War II, the U. S. has done very well on the life sciences R& D side, somewhat less well on the manufactur­ing side, and poorly on the fragmented delivery side,” she said.

Beefing up communicat­ion

Pitts said he has seen a shift in public attitudes in recent months from people dismissing the “Trump vaccine” to asking when and where they can get their shot.

“People understand both of these vaccines have been approved by the FDA without any shenanigan­s,” he said. “People are actively excited and anxious to get vaccinated.”

But Pitts has been frustrated by the lack of public education. With more than $ 10 billion spent on developing, manufactur­ing and distributi­ng the vaccines at the federal level, so far little money has gone to communicat­ing about when, where and why people should get vaccinated.

The Department of Health and Human Services has promised that a longdelaye­d education campaign aimed at encouragin­g Americans to get vaccinated will launch in January, but no date has been set.

Federal officials underestim­ated vaccine hesitancy and have failed to address many of the public’s questions, said Dr. William Schaffner, a professor and infectious disease expert at the Vanderbilt University School of Medicine in Nashville, Tennessee.

Schaffner said his own hospital conducted surveys, then launched an education campaign to help people understand the vaccine’s record and developmen­t process.

“We had Q& As for all different categories of employees who work at this medical center,” he said via email. “We actually saw the needle moving among all sectors.”

Vanderbilt has given initial shots to 18,000 employees so far, he said, and is now working on getting them the required second dose, while encouragin­g even more to get vaccinated.

One group that has remained hesitant, he said, are young women, who fear – despite no evidence or biological plausibili­ty – that the vaccine could affect their fertility.

“There’s a lot of nonsense on the Internet having to do with sterility and reproducti­ve health and the vaccine,” he said. “We did a video specifically on that topic for staff.”

Changing some people’s behavior will have a ripple effect, Schaffner said. “They look left and right to see what their peers are doing.”

The failure to launch such education campaigns has real- world consequenc­es, Pitts said.

Without an active effort to encourage vaccinatio­n among Black and Hispanic health care workers, many declined the vaccine when they had an early chance for a shot.

So now, instead of serving as the role models they could have been for others in their communitie­s, “we have respected health care members of communitie­s of color saying ‘ Don’t get vaccinated,’ ” Pitts said. “Not only did we not engage them to do the right thing, they’re actually out there now hurting the effort.”

Time for a rollout reset

All the panelists said they are looking forward to a new administra­tion.

“The Biden administra­tion is serious about ending the epidemic, and therefore they will certainly make a concerted effort to ensure mass vaccinatio­n,” Nagarkatti said, reflecting the group’s view.

Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelph­ia, said the rollout will get smoother with time and calmer under the new administra­tion. “At least we won’t be getting proclamati­ons of disdain for every science- based federal agency,” he said.

He said he is also looking forward to the arrival of spring and summer, when he believes enough people will be vaccinated to make a difference and the infection rate will naturally decline for a few months.

“All these good things are about to happen,” Offit said. “We will get a more humid climate. Good. We have an administra­tion that has a clue. Good. We have a vaccine that works really well. Good. And, the best part is it’s not going to be just these two vaccines.”

Two more vaccines are nearing completion of their clinical trials and will likely be authorized for use in February and March, Offit said, which “lightens the load in terms of production.”

Several panelists also had suggestion­s for what the Biden administra­tion should do to improve the vaccinatio­n campaign.

“Biden should create this new cadre of operations people who can help every state,” Yadav said. “If Florida says they don’t want it, then OK. But if a state wants it, we should be giving it to them.”

Vivian Riefberg, professor of practice at the Darden School of Business at the University of Virginia, said the new administra­tion should enlist as many approaches to vaccinatio­n as possible: mass distributi­on centers, community health facilities, physician’s offices, pharmacies, schools. “You’ve got to provide an array of places that administer vaccines,” she said.

Coordinati­on and communicat­ion must be improved between the federal and state government­s.

A better informatio­n technology system at the national level can help with registrati­on, enrollment and tracking, she said.

Right now, state systems are crashing because they are overloaded with people trying to sign up, leaving some on hold for hours or having to call dozens of times to get through. This disadvanta­ges people who are likely to be most in need of vaccinatio­n.

Finally, Riefberg said, the new administra­tion needs to address resistance to vaccinatio­n through education campaigns, enlisting trusted role models, even paying people to administer and receive shots, if necessary.

But she cautioned against expecting too much too quickly.

“We need to give the Biden people a chance to get off the ground here,” she said, “especially given the array of changes that are happening right now.”

 ??  ??
 ?? GETTY IMAGES ?? Officials failed to address many of the public’s questions about the COVID- 19 vaccine, Dr. William Schaffner says.
GETTY IMAGES Officials failed to address many of the public’s questions about the COVID- 19 vaccine, Dr. William Schaffner says.

Newspapers in English

Newspapers from United States